Medincell SA
PAR:MEDCL

Watchlist Manager
Medincell SA Logo
Medincell SA
PAR:MEDCL
Watchlist
Price: 16.76 EUR Market Closed
Market Cap: 490.1m EUR
Have any thoughts about
Medincell SA?
Write Note

Balance Sheet

Balance Sheet Decomposition
Medincell SA

Current Assets 27.3m
Cash & Short-Term Investments 19.5m
Receivables 6.7m
Other Current Assets 1.1m
Non-Current Assets 9.7m
Long-Term Investments 1.8m
PP&E 5.4m
Intangibles 2.5m
Current Liabilities 16.5m
Accounts Payable 1.8m
Accrued Liabilities 3.2m
Other Current Liabilities 11.5m
Non-Current Liabilities 61.3m
Long-Term Debt 52.8m
Other Non-Current Liabilities 8.5m

Balance Sheet
Medincell SA

Rotate your device to view
Balance Sheet
Currency: EUR
Mar-2017 Mar-2019 Mar-2020 Mar-2021 Mar-2022 Mar-2023 Mar-2024
Assets
Cash & Cash Equivalents
4
21
12
47
25
6
19
Cash
0
6
8
44
20
6
14
Cash Equivalents
4
15
4
3
5
0
5
Short-Term Investments
5
1
0
4
3
0
0
Total Receivables
1
3
4
5
6
12
7
Accounts Receivables
1
0
1
1
1
2
1
Other Receivables
0
3
4
4
5
11
5
Inventory
1
0
0
0
0
0
0
Other Current Assets
3
1
1
1
1
1
1
Total Current Assets
14
26
18
56
34
20
27
PP&E Net
2
3
4
4
7
6
5
PP&E Gross
0
3
4
4
7
6
5
Accumulated Depreciation
0
2
2
3
4
5
5
Intangible Assets
2
1
2
1
2
2
2
Long-Term Investments
3
5
4
2
2
1
2
Other Long-Term Assets
3
2
0
0
0
0
0
Total Assets
23
N/A
38
+63%
27
-28%
64
+133%
44
-30%
29
-34%
37
+26%
Liabilities
Accounts Payable
2
2
3
3
3
4
2
Accrued Liabilities
0
1
1
2
1
3
3
Short-Term Debt
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
1
3
1
3
28
40
6
Other Current Liabilities
3
1
1
6
6
10
5
Total Current Liabilities
5
8
7
14
38
57
16
Long-Term Debt
20
24
31
39
19
14
53
Minority Interest
0
0
0
0
0
0
0
Other Liabilities
0
0
5
2
0
0
9
Total Liabilities
26
N/A
32
+24%
43
+36%
54
+26%
58
+6%
72
+24%
78
+9%
Equity
Common Stock
0
0
0
0
0
0
0
Retained Earnings
0
27
49
66
21
50
72
Additional Paid In Capital
0
33
33
75
7
7
31
Other Equity
2
0
0
0
0
0
0
Total Equity
2
N/A
6
N/A
16
N/A
9
N/A
13
N/A
42
-216%
41
+3%
Total Liabilities & Equity
23
N/A
38
+63%
27
-28%
64
+133%
44
-30%
29
-34%
37
+26%
Shares Outstanding
Common Shares Outstanding
14
20
20
25
25
25
29

See Also

Discover More